BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30660205)

  • 1. Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Wang Y; Ye Z; Liu L; Cui X
    J Pharm Pharm Sci; 2019; 22(1):57-71. PubMed ID: 30660205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence.
    Kunutsor SK; Seidu S; Khunti K
    Ann Med; 2018 Sep; 50(6):529-537. PubMed ID: 30001640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between antidepressants and venous thromboembolism in Taiwan.
    Wu CS; Chang CM; Chen CY; Wu EC; Wu KY; Liang HY; Chao YL; Chung WS; Tsai HJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):31-7. PubMed ID: 23277236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
    Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis.
    Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A
    Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant drug use and risk of venous thromboembolism.
    Jick SS; Li L
    Pharmacotherapy; 2008 Feb; 28(2):144-50. PubMed ID: 18225961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis.
    Di X; Chen M; Shen S; Cui X
    Psychiatry Res; 2021 Feb; 296():113691. PubMed ID: 33421839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis.
    Qi X; Ren W; Guo X; Fan D
    Intern Emerg Med; 2015 Mar; 10(2):205-17. PubMed ID: 25472621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies.
    Gariani K; Mavrakanas T; Combescure C; Perrier A; Marti C
    Eur J Intern Med; 2016 Mar; 28():52-8. PubMed ID: 26507303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.
    Barbui C; Conti V; Cipriani A
    Drug Saf; 2014 Feb; 37(2):79-90. PubMed ID: 24403009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between migraine and risk of venous thromboembolism: A nationwide cohort study.
    Peng KP; Chen YT; Fuh JL; Tang CH; Wang SJ
    Headache; 2016 Sep; 56(8):1290-9. PubMed ID: 27411732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.
    Oh SW; Kim J; Myung SK; Hwang SS; Yoon DH
    Br J Clin Pharmacol; 2014 Oct; 78(4):727-37. PubMed ID: 24646010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.
    Ray JG; Mamdani MM; Yeo EL
    Thromb Haemost; 2002 Aug; 88(2):205-9. PubMed ID: 12195690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.
    Ambrosino P; Tarantino L; Di Minno G; Paternoster M; Graziano V; Petitto M; Nasto A; Di Minno MN
    Thromb Haemost; 2017 Jan; 117(1):139-148. PubMed ID: 27761574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis.
    Meng K; Hu X; Peng X; Zhang Z
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):245-53. PubMed ID: 24716782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of venous thromboembolism and physical activity level, especially high level: a systematic review.
    Danin-Mankowitz H; Ugarph-Morawski A; Braunschweig F; Wändell P
    J Thromb Thrombolysis; 2021 Aug; 52(2):508-516. PubMed ID: 33389612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal and monthly variability in the incidence of venous thromboembolism. A systematic review and a meta-analysis of the literature.
    Dentali F; Ageno W; Rancan E; Donati AV; Galli L; Squizzato A; Venco A; Mannucci PM; Manfredini R
    Thromb Haemost; 2011 Sep; 106(3):439-47. PubMed ID: 21725580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.